Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 166-176
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.166
Figure 2
Figure 2 Representative images of localized chronic eczema lesions before and 2 wk after treatment. Skin lesion of a patient in the intralesional 5-FU+TA treatment group (A) at baseline and (B) 2 wk after 5-FU+TA treatment. Skin lesion of a patient in the intralesional TA treatment group (C) at baseline and (D) 2 wk after TA treatment. 5-FU: 5-fluorouracil; TA: triamcinolone.